Efficacy of LY333328 against Experimental Methicillin-Resistant Staphylococcus aureus Endocarditis

The in vivo efficacy of LY333328, a new glycopeptide antibiotic, was compared with that of vancomycin by using the rabbit model of left-sided methicillin-resistant Staphylococcus aureus endocarditis. Animals received LY333328 or vancomycin (25 mg/kg of body weight every 24 or 8 h, respectively) for...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Kaatz, Glenn W., Seo, Susan M., Aeschlimann, Jeffrey R., Houlihan, Heather H., Mercier, Renee-Claude, Rybak, Michael J.
Formato: Artigo
Lenguaje:Inglês
Publicado: American Society for Microbiology 1998
Materias:
Experimental Therapeutics
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC105587/
https://ncbi.nlm.nih.gov/pubmed/9559828
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares